[
    [
        {
            "time": "2020-02-04",
            "original_text": "Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement",
            "features": {
                "keywords": [
                    "Lilly",
                    "Financial Results",
                    "Conference Call"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Confirms Date and Conference Call for Fourth-Quarter 2020 Financial Results Announcement",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-11-15",
            "original_text": "Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals",
            "features": {
                "keywords": [
                    "LLY",
                    "Alzheimer",
                    "NVS",
                    "SNY",
                    "M&A Deals"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-09-10",
            "original_text": "Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund",
            "features": {
                "keywords": [
                    "Lilly",
                    "Investment",
                    "Unseen Capital",
                    "Health Fund"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "venture capital"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]